3 E NETWORK TECHNOLOGY GRP-A (MASK) Stock Fundamental Analysis

NASDAQ:MASK • VGG8849D1107

0.1617 USD
+0 (+0.5%)
Last: Feb 26, 2026, 10:01 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Taking everything into account, MASK scores 4 out of 10 in our fundamental rating. MASK was compared to 87 industry peers in the IT Services industry. MASK has an average financial health and profitability rating. MASK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • MASK had positive earnings in the past year.
  • In the past year MASK had a positive cash flow from operations.
MASK Yearly Net Income VS EBIT VS OCF VS FCFMASK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 500K 1M 1.5M

1.2 Ratios

  • The Return On Assets of MASK (19.61%) is better than 97.70% of its industry peers.
  • The Return On Equity of MASK (34.26%) is better than 94.25% of its industry peers.
  • The Return On Invested Capital of MASK (40.30%) is better than 98.85% of its industry peers.
Industry RankSector Rank
ROA 19.61%
ROE 34.26%
ROIC 40.3%
ROA(3y)32.62%
ROA(5y)N/A
ROE(3y)51.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MASK Yearly ROA, ROE, ROICMASK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 50 100

1.3 Margins

  • MASK's Profit Margin of 23.03% is amongst the best of the industry. MASK outperforms 95.40% of its industry peers.
  • MASK's Profit Margin has declined in the last couple of years.
  • MASK's Operating Margin of 39.87% is amongst the best of the industry. MASK outperforms 98.85% of its industry peers.
  • MASK's Operating Margin has improved in the last couple of years.
  • MASK's Gross Margin of 50.26% is fine compared to the rest of the industry. MASK outperforms 75.86% of its industry peers.
  • MASK's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 39.87%
PM (TTM) 23.03%
GM 50.26%
OM growth 3Y1.96%
OM growth 5YN/A
PM growth 3Y-22.43%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
MASK Yearly Profit, Operating, Gross MarginsMASK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 500 1K 1.5K 2K 2.5K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • MASK has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, MASK has more shares outstanding
  • The debt/assets ratio for MASK is higher compared to a year ago.
MASK Yearly Shares OutstandingMASK Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 2M 4M 6M 8M 10M
MASK Yearly Total Debt VS Total AssetsMASK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 2M 4M 6M 8M

2.2 Solvency

  • MASK has an Altman-Z score of 3.42. This indicates that MASK is financially healthy and has little risk of bankruptcy at the moment.
  • MASK has a better Altman-Z score (3.42) than 66.67% of its industry peers.
  • MASK has a debt to FCF ratio of 78.28. This is a negative value and a sign of low solvency as MASK would need 78.28 years to pay back of all of its debts.
  • MASK's Debt to FCF ratio of 78.28 is on the low side compared to the rest of the industry. MASK is outperformed by 63.22% of its industry peers.
  • A Debt/Equity ratio of 0.20 indicates that MASK is not too dependend on debt financing.
  • The Debt to Equity ratio of MASK (0.20) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 78.28
Altman-Z 3.42
ROIC/WACC4.34
WACC9.28%
MASK Yearly LT Debt VS Equity VS FCFMASK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 1M 2M 3M 4M 5M

2.3 Liquidity

  • MASK has a Current Ratio of 2.46. This indicates that MASK is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.46, MASK is in the better half of the industry, outperforming 71.26% of the companies in the same industry.
  • MASK has a Quick Ratio of 2.46. This indicates that MASK is financially healthy and has no problem in meeting its short term obligations.
  • MASK has a better Quick ratio (2.46) than 71.26% of its industry peers.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 2.46
MASK Yearly Current Assets VS Current LiabilitesMASK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 2M 4M 6M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for MASK have decreased strongly by -13.61% in the last year.
  • The Earnings Per Share has been growing by 21.42% on average over the past years. This is a very strong growth
  • MASK shows a strong growth in Revenue. In the last year, the Revenue has grown by 107.85%.
  • The Revenue has been growing by 55.08% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-13.61%
EPS 3Y21.42%
EPS 5YN/A
EPS Q2Q%-46.15%
Revenue 1Y (TTM)107.85%
Revenue growth 3Y55.08%
Revenue growth 5YN/A
Sales Q2Q%462.69%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MASK Yearly Revenue VS EstimatesMASK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 1M 2M 3M 4M

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • MASK is valuated cheaply with a Price/Earnings ratio of 0.95.
  • 98.85% of the companies in the same industry are more expensive than MASK, based on the Price/Earnings ratio.
  • MASK's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.05.
Industry RankSector Rank
PE 0.95
Fwd PE N/A
MASK Price Earnings VS Forward Price EarningsMASK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, MASK is valued a bit more expensive than the industry average as 62.07% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 197.44
EV/EBITDA N/A
MASK Per share dataMASK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3 0.4

4.3 Compensation for Growth

  • The decent profitability rating of MASK may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for MASK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

3 E NETWORK TECHNOLOGY GRP-A

NASDAQ:MASK (2/26/2026, 10:01:24 AM)

0.1617

+0 (+0.5%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.11%
Inst Owner ChangeN/A
Ins Owners45.7%
Ins Owner ChangeN/A
Market Cap2.72M
Revenue(TTM)7.96M
Net Income(TTM)1.83M
AnalystsN/A
Price TargetN/A
Short Float %18.06%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.95
Fwd PE N/A
P/S 0.34
P/FCF 197.44
P/OCF 197.44
P/B 0.51
P/tB 0.51
EV/EBITDA N/A
EPS(TTM)0.17
EY105.13%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.51%
OCF(TTM)0
OCFY0.51%
SpS0.47
BVpS0.32
TBVpS0.32
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.1
Profitability
Industry RankSector Rank
ROA 19.61%
ROE 34.26%
ROCE 49.35%
ROIC 40.3%
ROICexc 42.37%
ROICexgc 42.37%
OM 39.87%
PM (TTM) 23.03%
GM 50.26%
FCFM 0.17%
ROA(3y)32.62%
ROA(5y)N/A
ROE(3y)51.38%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-24.87%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.87%
ROICexc growth 5YN/A
OM growth 3Y1.96%
OM growth 5YN/A
PM growth 3Y-22.43%
PM growth 5YN/A
GM growth 3Y-9.55%
GM growth 5YN/A
F-Score4
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 78.28
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0%
Interest Coverage 250
Cash Conversion N/A
Profit Quality 0.75%
Current Ratio 2.46
Quick Ratio 2.46
Altman-Z 3.42
F-Score4
WACC9.28%
ROIC/WACC4.34
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)10.33%
Cap/Sales(5y)N/A
Profit Quality(3y)50.38%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.61%
EPS 3Y21.42%
EPS 5YN/A
EPS Q2Q%-46.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)107.85%
Revenue growth 3Y55.08%
Revenue growth 5YN/A
Sales Q2Q%462.69%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y95.9%
EBIT growth 3Y58.12%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-98.51%
FCF growth 3Y-75.5%
FCF growth 5YN/A
OCF growth 1Y-98.51%
OCF growth 3Y-75.8%
OCF growth 5YN/A

3 E NETWORK TECHNOLOGY GRP-A / MASK FAQ

Can you provide the ChartMill fundamental rating for 3 E NETWORK TECHNOLOGY GRP-A?

ChartMill assigns a fundamental rating of 4 / 10 to MASK.


What is the valuation status for MASK stock?

ChartMill assigns a valuation rating of 3 / 10 to 3 E NETWORK TECHNOLOGY GRP-A (MASK). This can be considered as Overvalued.


Can you provide the profitability details for 3 E NETWORK TECHNOLOGY GRP-A?

3 E NETWORK TECHNOLOGY GRP-A (MASK) has a profitability rating of 6 / 10.


What is the valuation of 3 E NETWORK TECHNOLOGY GRP-A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for 3 E NETWORK TECHNOLOGY GRP-A (MASK) is 0.95 and the Price/Book (PB) ratio is 0.51.